GeneDx Holdings Corp. Number of Reportable Segments
GeneDx Holdings Corp. (WGS) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-03
- GeneDx Holdings Corp. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- GeneDx Holdings Corp. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment, a 50.00% decline year-over-year.
- GeneDx Holdings Corp. number of reportable segments for the quarter ending 2024-03-31 was 2.00 segment, a 0.00% change year-over-year.
- GeneDx Holdings Corp. number of reportable segments for the quarter ending 2023-06-30 was 2.00 segment.
- GeneDx Holdings Corp. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- GeneDx Holdings Corp. number of reportable segments for fiscal 2024 was 1.00 segment, a 50.00% decline from fiscal 2023.
- GeneDx Holdings Corp. number of reportable segments for fiscal 2023 was 2.00 segment, a 0.00% change from fiscal 2022.
- GeneDx Holdings Corp. number of reportable segments for fiscal 2022 was 2.00 segment, a 100.00% increase from fiscal 2021.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-03 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-23 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-04-30 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-20 | |||
| 2024-09-30 | 2.00 segment 10-Q · filed 2024-10-29 | |||
| 2024-06-30 | 2.00 segment 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | 2.00 segment 10-Q · filed 2024-04-29 | |||
| 2023-12-31 | 2.00 segment 10-K · filed 2024-02-23 | |||
| 2023-09-30 | 2.00 segment 10-Q · filed 2023-11-03 | |||
| 2023-06-30 | 2.00 segment 10-Q · filed 2023-08-08 | 2.00 segment 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | 2.00 segment 10-Q · filed 2023-05-09 | 1.00 segment 10-Q · filed 2023-08-08 | ||
| 2022-12-31 | 2.00 segment 10-Q · filed 2023-05-09 | 2.00 segment 10-K · filed 2023-03-16 | ||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |